Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTRK1 | P04629 | 2/20 | 0.36 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.36 |
| ▸ | NTRK2 | Q16620 | 1/20 | 0.36 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.35 |
| ▸ | CFTR | P13569 | 3/20 | 0.35 |
| ▸ | EIF2AK3 | Q9NZJ5 | 3/20 | 0.34 |
| ▸ | KDR | P35968 | 2/20 | 0.34 |
| ▸ | NEK7 | Q8TDX7 | 2/20 | 0.32 |
| ▸ | FLT3 | P36888 | 3/20 | 0.32 |
| ▸ | EGFR | P00533 | 3/20 | 0.32 |
| ▸ | ABL1 | P00519 | 2/20 | 0.32 |
| ▸ | ABL2 | P42684 | 2/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | AXL | P30530 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20182289 | 0.92 | NTRK1 (0.36) | NTRK1NTRK3NTRK2EIF2AK3KDR | |
| SCHEMBL20181916 | 0.92 | CFTR (0.39) | CFTREIF2AK3KDREGFRABL1 | |
| SCHEMBL20182292 | 0.90 | NEK7 (0.37) | NTRK1NTRK3NTRK2EIF2AK3KDR | |
| SCHEMBL20182191 | 0.90 | ALK (0.34) | ALKCFTREIF2AK3KDREGFR | |
| SCHEMBL20182271 | 0.89 | CFTR (0.35) | ALKCFTREIF2AK3KDREGFR | |
| SCHEMBL20182235 | 0.86 | EIF2AK3 (0.34) | NTRK1NTRK3NTRK2EIF2AK3KDR | |
| SCHEMBL20182194 | 0.86 | EIF2AK3 (0.36) | CFTREIF2AK3KDREGFRABL1 | |
| SCHEMBL20182224 | 0.85 | EGFR (0.39) | CFTRKDREGFRABL1ABL2 | |
| SCHEMBL20182291 | 0.85 | NTRK1 (0.38) | NTRK1NTRK3NTRK2EIF2AK3KDR | |
| SCHEMBL20182294 | 0.84 | CFTR (0.40) | NTRK1NTRK3NTRK2CFTREIF2AK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018094137-A1 | PYRROLOPYRIMIDINES AS CFTR POTENTIATORS | CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) | 2018-05-24 | — | — | WO | disclosed |